Summary
Tyler Harvey is a biology leader with a decade of experience advancing liver-directed gene editing programs from early research through IND-enabling studies. As Associate Director of Liver Biology in Nonclinical Development at Prime Medicine, he shapes translational strategy, aligns cross-functional teams, and has supported major regulatory interactions including Type B/D meetings, IND submissions, and Health Canada pre-CTA activities. He builds and mentors high-performing PhD teams, contributes to intellectual property as a named inventor, and translates complex biological questions into decisive experimental plans. Trained as a developmental biologist (PhD, Johns Hopkins) with deep roots in stem cell and extracellular matrix biology, he brings uncommon comfort bridging fundamental biology, single-cell genomics, and practical regulatory development to accelerate therapeutic impact.
10 years of coding experience
8 years of employment as a software developer
Johns Hopkins University
Bachelor's degree, Biology/Biological Sciences, General, Bachelor's degree, Biology/Biological Sciences, General at Marquette University
English, Spanish